HCPCS Level IIdrugActive
J0480
Basiliximab
BETOS: O1E
Effective: 2006-01-01
Referenced in 2 policies
Description
Injection, basiliximab, 20 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Simulect
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
20 MG
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.